特发性正常压力脑积水的分流手术具有成本效益——一项成本效用分析
研究评估特发性正常压力脑积水(iNPH)患者分流手术的成本效益,对30例患者(中位年龄71岁,范围65-89岁)术前及术后6个月用EQ-5D-3L评估健康相关生活质量,并详细调查手术相关成本。采用决策分析马尔可夫模型、社会视角和终生时间范围估算成本与效果,结果显示分流手术作为标准治疗可增加2.2个生命年和1.7个质量调整生命年(QALY),每例患者增量成本为7500欧元/QALY,敏感性分析表明结果对不确定参数或假设的变化不敏感。
要点
- 分流手术作为iNPH标准治疗可增加2.2个生命年和1.7个QALY,每例增量成本为7500欧元/QALY。
- 敏感性分析显示结果对不确定参数或假设的变化不敏感。
- 分流手术不仅是有效的医疗手段,对约70岁个体而言也具有成本效益。
核心结论
- iNPH的分流手术不仅是有效的医疗手段,也具有成本效益,以低成本增加2.2个额外生命年和1.7个QALY,对约70岁个体是显著获益。
研究设计与样本
- 对30例诊断为iNPH的患者(中位年龄71岁,范围65-89岁)在术前和术后6个月使用EQ-5D-3L评估健康相关生活质量。
- 通过详细调查(访谈和提取登记数据)评估分流手术相关成本,包括医院护理、初级保健、住院护理、家庭护理服务和非正式护理的成本。
- 未治疗患者的成本来源于瑞典国家健康与福利委员会报告的2012年瑞典痴呆症疾病成本。
- 成本效益分析使用决策分析马尔可夫模型,采用社会视角和终生时间范围估算成本和效果。
- 进行单因素敏感性分析和概率敏感性分析以检验模型的稳健性。
主要发现
- 分流手术模型作为iNPH的标准治疗导致增加2.2个生命年和1.7个质量调整生命年(QALY),每例患者增量成本为7500欧元/QALY。
- 敏感性分析显示结果对不确定参数或假设的变化不敏感。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The objective was to evaluate the cost-effectiveness of shunt surgery in patients with idiopathic normal pressure hydrocephalus (iNPH). METHODS: Health-related quality of life was evaluated before and 6 months after surgery using the EQ-5D-3 L (EuroQOL group five-dimensions health survey) in 30 patients (median age, 71 years; range, 65-89 years) diagnosed with iNPH. The costs associated with shunt surgery were assessed by a detailed survey with interviews and extraction of register data concerning the cost of hospital care, primary care, residential care, home-care service and informal care. The cost of untreated patients was derived from the cost of dementia disorders in Sweden in 2012, as reported by the National Board of Health and Welfare. The cost effectiveness analysis used a decision-analytic Markov model. We used a societal perspective and a lifelong time horizon to estimate costs and effects. One-way sensitivity analysis and probabilistic sensitivity analysis were carried out to test the robustness of the model. RESULTS: The shunt surgery model as the standard treatment in iNPH resulted in a gain of 2.2 life years and 1.7 quality-adjusted life years (QALY), along with an incremental cost per patient of €7,500/QALY. The sensitivity analysis showed that the results were not sensitive to changes in uncertain parameters or assumptions. CONCLUSIONS: Shunt surgery in iNPH, an underdiagnosed condition severely impairing elderly patients, is not only an effective medical treatment, it is also cost-effective, adding 2.2 additional life years and 1.7 QALYs at a low cost, a remarkable gain for an individual aged around 70 years.
引用
- Tullberg M, Persson J, Petersen J, et al. Shunt surgery in idiopathic normal pressure hydrocephalus is cost-effective-a cost utility analysis. Acta Neurochir (Wien). 2017. PMID: 29150794. doi:10.1007/s00701-017-3394-7
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。